Functional Dyspepsia
Conditions
Interventions
The groups of electroacupuncture at Zusanli (ST36) and Shangjuxu (ST37) acupoint:Electroacupuncture applied to bilateral Zusanli (ST36) and Shangjuxu (ST37) acupoints with dispersed-dense wave for 30
The group of electroacupuncture on non-meridian and non-acupoints area next to Zusanli (ST36) and Shangjuxu(ST37) acupoint:Electroacupuncture applied to bilateral non-meridian and non-acupoints area n
The group of electroacupuncture on Zusanli (ST36) and non-meridian and non-acupoints area next to Shangjuxu(ST37) acupoint:Electroacupuncture applied to bilateral Zusanli (ST36) and non-meridian and
The group of electroacupuncture on non-meridian and non-acupoints area next to Zusanli (ST36) and non-meridian and non-acupoints area next to Shangjuxu(ST37) acupoint:Electroacupuncture applied to b
Sponsors
Wangjing Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Meeting the diagnostic criteria for functional dyspepsia syndrome as established by the Academic Committee of Rome IV in 2016. 2.Aged 18 to 75 years. 3.Abstaining from the use of medications related to the treatment of the condition for at least one week prior to study entry, and not participating in concurrent studies. 4.Voluntarily participating in the trial and providing informed consent personally. 5.Maintaining a permanent residence in the treatment location, conducive to therapy and follow-up.
Exclusion criteria
Exclusion criteria: 1.Patients with gastric or duodenal ulcers, erosions, reflux esophagitis, and other related conditions identified through gastroscopy. 2.Patients with gallbladder inflammation, gallstones, and hepatic, biliary, splenic, or pancreatic issues detected via abdominal ultrasonography. 3.Coexisting metabolic disorders affecting gastrointestinal motility, such as thyroid disorders and diabetes. 4.Patients with tumors and organic lesions in the heart, liver, or kidneys, as well as individuals with mental health disorders. 5.Pregnant or lactating women and female patients with recent plans for conception. 6.Patients whose circumstances, as determined by the investigator, may lower the likelihood of successful enrollment or complicate their participation, such as frequently changing work environments that could lead to loss to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nepean Dyspepsia Symptom Index;Serum brain-gut peptide;Safety assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Nepean Dyspepsia Symptom Index;Overall symptom response rate (participants with functional dyspepsia);FD single symptom scale;Nepean Dyspepsia Index Life Quality Index;Hamilton Anxiety Scale;Hamilton Depression Scale;Electrogastrogram;Heart rate variability; | — |
Countries
China
Contacts
Public ContactXiaolan Su
Wangjing Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed